This paper outlines a proposal for the collection and reporting of information on off-label use by Marketing Authorisation Holders (MAHs) in relation to their pharmacovigilance obligations provided in Title IX of Directive 2001/83/EC.

 

Posted on the EMA website on 29 April 2016